News Feed

Soligenix Announces Recent Accomplishments And Third Quarter 2019 Financial Results

Soligenix’s revenues for the quarter ended September 30, 2019 were $1.3 million as compared to $1.4 million for the quarter ended September 30, 2018. Revenues included payments on a contract in support of RiVax®, in addition to the grants received to support the development of SGX301 […]